Cargando…
Risk of Major Adverse Cardiovascular Events and Major Hemorrhage Among White and Black Patients Undergoing Percutaneous Coronary Intervention
BACKGROUND: Data on racial disparities in major adverse cardiovascular events (MACE) and major hemorrhage (HEM) after percutaneous coronary intervention are limited. Factors contributing to these disparities are unknown. METHODS AND RESULTS: PRiME‐GGAT (Pharmacogenomic Resource to Improve Medication...
Autores principales: | Cai, Anping, Dillon, Chrisly, Hillegass, William B., Beasley, Mark, Brott, Brigitta C., Bittner, Vera A., Perry, Gilbert J., Halade, Ganesh V., Prabhu, Sumanth D., Limdi, Nita A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915255/ https://www.ncbi.nlm.nih.gov/pubmed/31701784 http://dx.doi.org/10.1161/JAHA.119.012874 |
Ejemplares similares
-
Risk of Postdischarge Bleeding From Dual Antiplatelet Therapy After Percutaneous Coronary Intervention Among US Black and White Adults
por: Heindl, Brittain, et al.
Publicado: (2022) -
Race‐based and sex‐based differences in bioactive lipid mediators after myocardial infarction
por: Halade, Ganesh V., et al.
Publicado: (2020) -
Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017) -
Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction
por: Halade, Ganesh V., et al.
Publicado: (2016) -
Oral antiplatelet therapy in diabetes mellitus and the role of prasugrel: an overview
por: Hillegass, William B, et al.
Publicado: (2011)